These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24590509)

  • 41. Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors.
    Kerckhove N; Boudieu L; Ourties G; Bourdier J; Daulhac L; Eschalier A; Mallet C
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1419-1432. PubMed ID: 31767519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of Ca
    Liu QY; Chen W; Cui S; Liao FF; Yi M; Liu FY; Wan Y
    Neurosci Res; 2019 May; 142():30-37. PubMed ID: 29684385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
    Choe W; Messinger RB; Leach E; Eckle VS; Obradovic A; Salajegheh R; Jevtovic-Todorovic V; Todorovic SM
    Mol Pharmacol; 2011 Nov; 80(5):900-10. PubMed ID: 21821734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Icilin reduces voltage-gated calcium channel currents in naïve and injured DRG neurons in the rat spinal nerve ligation model.
    Hagenacker T; Lampe M; Schäfers M
    Brain Res; 2014 Apr; 1557():171-9. PubMed ID: 24560602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of peripheral T-type calcium channels in pain transmission.
    Jevtovic-Todorovic V; Todorovic SM
    Cell Calcium; 2006 Aug; 40(2):197-203. PubMed ID: 16777222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Voltage-gated calcium channels as targets for the treatment of chronic pain.
    McGivern JG; McDonough SI
    Curr Drug Targets CNS Neurol Disord; 2004 Dec; 3(6):457-78. PubMed ID: 15578964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of T-type calcium channels in peripheral and central pain processing.
    Todorovic SM; Jevtovic-Todorovic V
    CNS Neurol Disord Drug Targets; 2006 Dec; 5(6):639-53. PubMed ID: 17168748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central and peripheral contributions of T-type calcium channels in pain.
    Harding EK; Zamponi GW
    Mol Brain; 2022 May; 15(1):39. PubMed ID: 35501819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Huwentoxin-XVI, an analgesic, highly reversible mammalian N-type calcium channel antagonist from Chinese tarantula Ornithoctonus huwena.
    Deng M; Luo X; Xiao Y; Sun Z; Jiang L; Liu Z; Zeng X; Chen H; Tang J; Zeng W; Songping Liang
    Neuropharmacology; 2014 Apr; 79():657-67. PubMed ID: 24467846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic intrathecal infusion of T-type calcium channel blockers attenuates Ca
    Shiue SJ; Wang CH; Wang TY; Chen YC; Cheng JK
    Acta Anaesthesiol Taiwan; 2016 Sep; 54(3):81-87. PubMed ID: 27765616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-6 induced upregulation of T-type Ca
    Jeevakumar V; Al Sardar AK; Mohamed F; Smithhart CM; Price T; Dussor G
    J Neurophysiol; 2020 Jul; 124(1):274-283. PubMed ID: 32519575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel α-conopeptide Eu1.6 inhibits N-type (Ca
    Liu Z; Bartels P; Sadeghi M; Du T; Dai Q; Zhu C; Yu S; Wang S; Dong M; Sun T; Guo J; Peng S; Jiang L; Adams DJ; Dai Q
    Sci Rep; 2018 Jan; 8(1):1004. PubMed ID: 29343689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacology and Mechanism of Action of HSK16149, a Selective Ligand of
    Gou X; Yu X; Bai D; Tan B; Cao P; Qian M; Zheng X; Chen L; Shi Z; Li Y; Ye F; Liang Y; Ni J
    J Pharmacol Exp Ther; 2021 Mar; 376(3):330-337. PubMed ID: 33293377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
    Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
    ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low threshold T-type calcium channels as targets for novel epilepsy treatments.
    Powell KL; Cain SM; Snutch TP; O'Brien TJ
    Br J Clin Pharmacol; 2014 May; 77(5):729-39. PubMed ID: 23834404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of T-type calcium channels in epilepsy and pain.
    Nelson MT; Todorovic SM; Perez-Reyes E
    Curr Pharm Des; 2006; 12(18):2189-97. PubMed ID: 16787249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats.
    Scott VE; Vortherms TA; Niforatos W; Swensen AM; Neelands T; Milicic I; Banfor PN; King A; Zhong C; Simler G; Zhan C; Bratcher N; Boyce-Rustay JM; Zhu CZ; Bhatia P; Doherty G; Mack H; Stewart AO; Jarvis MF
    Biochem Pharmacol; 2012 Feb; 83(3):406-18. PubMed ID: 22153861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain.
    Hildebrand ME; Smith PL; Bladen C; Eduljee C; Xie JY; Chen L; Fee-Maki M; Doering CJ; Mezeyova J; Zhu Y; Belardetti F; Pajouhesh H; Parker D; Arneric SP; Parmar M; Porreca F; Tringham E; Zamponi GW; Snutch TP
    Pain; 2011 Apr; 152(4):833-843. PubMed ID: 21349638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of T-type calcium channels in the peripheral pain pathway.
    Todorovic SM; Jevtovic-Todorovic V
    Channels (Austin); 2007; 1(4):238-45. PubMed ID: 18708751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine.
    Ross HR; Gilmore AJ; Connor M
    Br J Pharmacol; 2009 Mar; 156(5):740-50. PubMed ID: 19226289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.